EORTC-NCI-AACR Symposium welcomes the interest of the press in cancer issues and is happy to provide assistance to journalists viewing presentations made at the virtual Symposium or using the Symposium website as a resource in their coverage of cancer issues.
The virtual Symposium is open to bona fide representatives of print and electronic media, and registration is free.
To access the press conferences and to receive official symposium press releases, journalists must register for the Symposium and be in possession of a valid, recognised press card. Freelance journalists must supply a commissioning letter on headed paper from a recognised news organisation or publication.
To register and to supply a copy of your press card or of the commissioning letter click below:
Journalists must register in person. Applications for media registration made via pharmaceutical, marketing or public relations companies will not be considered.
Media registration in advance is strongly recommended. This enables us to deal with any queries or problems in advance.
PLEASE NOTE: Representatives of public relations companies, advertising agencies, marketing companies, pharmaceutical companies, financial analysts and their publications are not permitted to register as journalists or to view the official press conference, but they are welcome to register as regular participants at the Symposium.
Information regarding media registrations belongs to EORTC and the media consultants. Past and current media lists are not available to be given, rented, or sold.
Journalists and third parties are requested to respect the embargo policy. Should an embargo be broken, both the third party and the journalist concerned will be held responsible.
The majority of the Symposium poster abstracts (including posters in poster discussion sessions) will go on line on the Symposium web page at 09:00 Central European Summer Time (CEST) on 9 October 2020 at www.eortc.org/ena and can be reported from that time onwards.
Oral and Late breaking abstracts will not be published until 10.00 hrs CEST/CET on the day they are to be presented to the Symposium (Saturday is on Central European Summer time, but the clocks go back on Sunday to Central European Time). Abstracts that form part of the official media programme will be published by 10.00 hrs CEST/CET on the day they are to be presented to the Symposium or on the day to which they are embargoed, if earlier. Embargo dates and times are given on the press releases. When asking for outside comment on releases before the embargo has lifted, journalists are requested to ensure that those consulted understand and accept the embargo conditions.
Posters and pre-recorded presentations to the Symposium will go online on the first day of the Symposium and can be reported from this time unless they are the subject of an official Symposium press release with an earlier embargo. Live presentations can be viewed at www.eortc.org/ena and can be reported from the start of the session in which they are presented unless they are the subject of an official Symposium press release with an earlier embargo.
Official media materials will be made available to registered journalists only.
Use of images and slides from posters and presentations
Journalists may include information and images from Symposium presentations in their reports and share them on social media with the following exceptions:
- Oral presenters may label any or all of their slides in their presentations with “DO NOT POST”.
- Poster presenters may label their posters with “DO NOT POST”.
In these circumstances, journalists are asked to respect the presenters’ requests.
Opening Press Conference
The opening press conference for the Symposium will take place at 17.00 hrs CEST on Tuesday 20 October. It will be chaired by the co-chairs of the meeting:
- Emiliano Calvo, START Madrid, Hospital de Madrid Norte Sanchinarro, Madrid, Spain (EORTC)
- William Sellers, Broad Institute of MIT and Harvard, Cambridge, Massachusetts (AACR)
- James Gulley, National Cancer Institute, Bethesda, Maryland (NCI)
During the Symposium around 2,000 international experts in the cancer field will be discussing innovations in drug development, ground-breaking new data, the selection of new targets for anti-cancer drugs, and the impact of new discoveries in molecular biology, in order to improve the survival and quality of life of cancer patients.
If you have any questions about the media programme, contact: Emma Mason, EORTC media consultant
Tel: +44 (0)1376 563090, mobile: +44 (0)7711 296 986, email: email@example.com
Third Party Media Events
Companies or other organisations wishing to organise a news conference or any other event for the media during the Symposium should email their request to Gwydion Lyn, Events and Communication Co-ordinator at Gwydion.firstname.lastname@example.org.
Any media event must pertain to presentations being made to the Symposium in oral (live or pre-recorded) or poster sessions. Reference to the Symposium can only be made in connection with scientific presentations planned in the official programme of the meeting. The programme and invitations for any third party media event should be submitted to and agreed by the ENA Secretariat (email@example.com) before any invitations are sent out.
Third party press releases must be labelled clearly with the abstract number, time and date of presentation to the Symposium, and submitted to, and agreed by the ENA Secretariat (firstname.lastname@example.org) before they are issued to the media. Third party press releases relating to any abstracts that are being held back for publication online on the day of presentation to the Symposium (i.e. those that form part of the official media programme, or oral or late breaking abstracts) must be embargoed either to match the embargo on the Symposium’s official press releases, or, if they are not the subject of an official press release, to the time of the start of the session in which they are being presented if the information contained within them goes beyond that in the abstracts. If the information in the press release does not go beyond the abstracts, they should be embargoed to 10.00 hrs CEST/CET on the day of presentation. Please check with the Symposium media consultant Emma Mason for information about the exact times of embargoes on these abstracts.
Third party media materials must not contain the EORTC, NCI or AACR logos and must not be presented in any way that could be construed as suggesting endorsement by the Symposium, the EORTC, NCI or AACR.
Confidentiality policy for third parties
All abstracts accepted for presentation at the EORTC-NCI-AACR Symposium are considered to be confidential from the time the abstract is submitted to the Symposium until public release at the Symposium. No information regarding abstracts should be issued until the time the poster abstracts are published online (9 October 2020) or their presentation at the Symposium – whichever is earlier. If there is any breach of confidentiality, the abstract will no longer be eligible for inclusion in the Symposium programme.
The EORTC-NCI-AACR recognise that there are some instances when a publicly traded company is required to disclose data or other information from an abstract in advance of its public release at the meeting in order to satisfy requirements of the US Securities and Exchange Commission (SEC) or a corresponding body in another country. In such a case, the abstract will still be eligible for inclusion in the Symposium programme, but the company must contact Gwydion Lyn in advance to notify him that a press release is required in accordance with SEC regulations. Any such press release must be seen and approved by ENA Secretariat prior to its release. It should contain the minimum amount of information required by the SEC, and should avoid including all the exact details and data contained within the Symposium abstract. It should avoid discussing implications of the data for future research and/or clinical practice, and it should mention that full data will be presented at the 32nd EORTC-NCI-AACR Symposium.
If third parties have any questions about the media policy please contact Gwydion Lyn, Events and Communication Co-ordinator at email@example.com.